Journal:IUCrJ:S2052252522006820

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 20: Line 20:
*<scene name='94/949060/Cv/13'>BSA-ketoprofen</scene> (PDB ID: [[6qs9]]).
*<scene name='94/949060/Cv/13'>BSA-ketoprofen</scene> (PDB ID: [[6qs9]]).
*<scene name='94/949060/Cv/14'>LSA-ketoprofen</scene> (PDB ID: [[6ock]]).
*<scene name='94/949060/Cv/14'>LSA-ketoprofen</scene> (PDB ID: [[6ock]]).
-
*<scene name='94/949060/Cv/15'>HSA-ligand free</scene> (PDB ID: [[4k2c]]).
+
*<scene name='94/949060/Cv/15'>HSA-ligand free</scene> (PDB ID: [[4k2c]]).
 +
*<scene name='94/949060/Cv/16'>HSA-myristic acid</scene> (PDB ID: [[1bj5]]).
The results reported herein provide insight into the circulatory transport of ketoprofen, a popular nonsteroidal anti-inflammatory drug (NSAID), across species. The structure of the ketoprofen complex with human SA revealed that four ketoprofen molecules bind to three distinct sites within SA, which only partially overlap with sites previously reported to bind ketoprofen in SAs from other species. We explored the reasons for the observed differences, including identifying residues and interactions required for ketoprofen binding at specific sites and the influence of metabolites and components of crystallization solution on drug binding. The presented results reveal that the drug-binding properties of albumins cannot be easily predicted based only on a complex of albumin from another organism and the conservation of drug sites between species. This work shows that understanding organism-dependent differences is essential for assessing the suitability of particular albumins for structural or biochemical studies.
The results reported herein provide insight into the circulatory transport of ketoprofen, a popular nonsteroidal anti-inflammatory drug (NSAID), across species. The structure of the ketoprofen complex with human SA revealed that four ketoprofen molecules bind to three distinct sites within SA, which only partially overlap with sites previously reported to bind ketoprofen in SAs from other species. We explored the reasons for the observed differences, including identifying residues and interactions required for ketoprofen binding at specific sites and the influence of metabolites and components of crystallization solution on drug binding. The presented results reveal that the drug-binding properties of albumins cannot be easily predicted based only on a complex of albumin from another organism and the conservation of drug sites between species. This work shows that understanding organism-dependent differences is essential for assessing the suitability of particular albumins for structural or biochemical studies.

Revision as of 13:37, 2 February 2023

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky, Jaime Prilusky

This page complements a publication in scientific journals and is one of the Proteopedia's Interactive 3D Complement pages. For aditional details please see I3DC.
Personal tools